Exploring the Interplay of Microbiome, Bile Acids, Immune Reconstitution, and Clinical Outcomes Following Allogeneic Hematopoietic Transplantation in Pediatrics |
Memorial Sloan-Kettering Cancer Center / Oriana Miltiadous, MD |
Reach Grants |
2024 |
New York |
Targeting protein synthesis in pediatric acute myeloid leukemia |
Cincinnati Children's Hospital Medical Center / Courtney Jones, PhD |
'A' Award Grants |
2024 |
Ohio |
Systematic screening of receptor pairs combinations for improving solid tumor cancer immunotherapy |
Baylor College of Medicine / Xavier Rios, MD/PhD |
'A' Award Grants |
2024 |
Texas |
Targeting the immunosuppressive effects of Myc-hyperactivation in high-risk osteosarcoma |
Emory University / Jason Yustein, MD/PhD |
Innovation Grants |
2024 |
Georgia |
Targeting and imaging immunometabolic vulnerabilities in diffuse midline glioma |
The Regents of the University of California San Francisco / Pavithra Viswanath, PhD |
Innovation Grants |
2024 |
California |
The role of tissue kallikrein 1 in hematopoietic stem cell transplant-associated thrombotic microangiopathy |
Baylor College of Medicine / Sarah Sartain, MD |
Innovation Grants |
2024 |
Texas |
Targeting of a putative unresolved wound healing process in childhood ependymoma |
University of Colorado Denver / Nicholas Foreman, MD |
Innovation Grants |
2024 |
Colorado |
Direct targeting of oncoprotein assembly using mimetic peptide interference |
Memorial Sloan-Kettering Cancer Center / Alex Kentsis, MD/PhD |
Innovation Grants |
2024 |
New York |
Investigating the impact of osteosarcoma genetic lesions on bone differentiation |
Dana-Farber Cancer Institute / James Morrow, MD/PhD |
Young Investigator Grants |
2024 |
Massachusetts |
Investigating mechanistic roles of a novel oncofusion-driven transcript isoform in Ewing sarcoma |
BC Cancer (Provincial Health Services Authority) / Poul Sorensen, MD/PhD |
Innovation Grants |
2024 |
British Columbia |